Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Seth

Showing results (331-340 of 415) with videos related to

Pageof 42
Sort By:
The American Journal of Tropical Medicine and Hygiene|August 27, 1999
Acceleration of viral replication and up-regulation of cytokine levels by antimalarials: implications in malaria-endemic areasP Seth, H Mani, A K Singh, et al.
ACS Medicinal Chemistry Letters|June 18, 2021
Site-specific Incorporation of 2',5'-Linked Nucleic Acids Enhances Therapeutic Profile of Antisense OligonucleotidesThazha P Prakash, Jinghua Yu, Wen Shen, et al.
Nucleic Acids Research|February 25, 2016
Stabilin-1 and Stabilin-2 are specific receptors for the cellular internalization of phosphorothioate-modified antisense oligonucleotides (ASOs) in the liverColton M Miller, Aaron J Donner, Emma E Blank, et al.
Nucleic Acid Therapeutics|July 21, 2022
The Combination of Mesyl-Phosphoramidate Inter-Nucleotide Linkages and 2'-<i>O</i>-Methyl in Selected Positions in the Antisense Oligonucleotide Enhances the Performance of RNaseH1 Active PS-ASOsLingdi Zhang, Xue-Hai Liang, Cheryl Li De Hoyos, et al.
Nucleic Acid Therapeutics|April 28, 2017
Co-Administration of an Excipient Oligonucleotide Helps Delineate Pathways of Productive and Nonproductive Uptake of Phosphorothioate Antisense Oligonucleotides in the LiverAaron J Donner, Edward V Wancewicz, Heather M Murray, et al.
Nucleic Acids Research|April 3, 2012
TricycloDNA-modified oligo-2'-deoxyribonucleotides reduce scavenger receptor B1 mRNA in hepatic and extra-hepatic tissues--a comparative study of oligonucleotide length, design and chemistrySue Murray, Damian Ittig, Erich Koller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2009
In vivo enhancement of peptide display by MHC class II molecules with small molecule catalysts of peptide exchangeMelissa J Call, Xuechao Xing, Gregory D Cuny, et al.
Journal of the American Chemical Society|March 24, 2020
Origins of the Increased Affinity of Phosphorothioate-Modified Therapeutic Nucleic Acids for ProteinsMalwina Hyjek-Składanowska, Timothy A Vickers, Agnieszka Napiórkowska, et al.
Cancer Gene Therapy|June 30, 2012
Intravenous administration of adenoviruses targeting transforming growth factor beta signaling inhibits established bone metastases in 4T1 mouse mammary tumor model in an immunocompetent syngeneic hostZ Zhang, Z Hu, J Gupta, et al.
Journal of Medicinal Chemistry|November 10, 2010
Configuration of the 5'-methyl group modulates the biophysical and biological properties of locked nucleic acid (LNA) oligonucleotidesPunit P Seth, Charles R Allerson, Andrew Siwkowski, et al.
Pageof 42

Showing results (331-340 of 415) with videos related to

Sort By:
Pageof 42
The American Journal of Tropical Medicine and Hygiene|August 27, 1999
Acceleration of viral replication and up-regulation of cytokine levels by antimalarials: implications in malaria-endemic areasP Seth, H Mani, A K Singh, et al.
ACS Medicinal Chemistry Letters|June 18, 2021
Site-specific Incorporation of 2',5'-Linked Nucleic Acids Enhances Therapeutic Profile of Antisense OligonucleotidesThazha P Prakash, Jinghua Yu, Wen Shen, et al.
Nucleic Acids Research|February 25, 2016
Stabilin-1 and Stabilin-2 are specific receptors for the cellular internalization of phosphorothioate-modified antisense oligonucleotides (ASOs) in the liverColton M Miller, Aaron J Donner, Emma E Blank, et al.
Nucleic Acid Therapeutics|July 21, 2022
The Combination of Mesyl-Phosphoramidate Inter-Nucleotide Linkages and 2'-<i>O</i>-Methyl in Selected Positions in the Antisense Oligonucleotide Enhances the Performance of RNaseH1 Active PS-ASOsLingdi Zhang, Xue-Hai Liang, Cheryl Li De Hoyos, et al.
Nucleic Acid Therapeutics|April 28, 2017
Co-Administration of an Excipient Oligonucleotide Helps Delineate Pathways of Productive and Nonproductive Uptake of Phosphorothioate Antisense Oligonucleotides in the LiverAaron J Donner, Edward V Wancewicz, Heather M Murray, et al.
Nucleic Acids Research|April 3, 2012
TricycloDNA-modified oligo-2'-deoxyribonucleotides reduce scavenger receptor B1 mRNA in hepatic and extra-hepatic tissues--a comparative study of oligonucleotide length, design and chemistrySue Murray, Damian Ittig, Erich Koller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2009
In vivo enhancement of peptide display by MHC class II molecules with small molecule catalysts of peptide exchangeMelissa J Call, Xuechao Xing, Gregory D Cuny, et al.
Journal of the American Chemical Society|March 24, 2020
Origins of the Increased Affinity of Phosphorothioate-Modified Therapeutic Nucleic Acids for ProteinsMalwina Hyjek-Składanowska, Timothy A Vickers, Agnieszka Napiórkowska, et al.
Cancer Gene Therapy|June 30, 2012
Intravenous administration of adenoviruses targeting transforming growth factor beta signaling inhibits established bone metastases in 4T1 mouse mammary tumor model in an immunocompetent syngeneic hostZ Zhang, Z Hu, J Gupta, et al.
Journal of Medicinal Chemistry|November 10, 2010
Configuration of the 5'-methyl group modulates the biophysical and biological properties of locked nucleic acid (LNA) oligonucleotidesPunit P Seth, Charles R Allerson, Andrew Siwkowski, et al.
Pageof 42